These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8538846)

  • 1. The role of antiphospholipid antibodies in lupus nephropathy.
    Perdiguero M; Boronat M; Marco P; Rivera F
    Nephron; 1995; 71(1):35-9. PubMed ID: 8538846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiphospholipid Antibodies in Lupus Nephritis.
    Parodis I; Arnaud L; Gerhardsson J; Zickert A; Sundelin B; Malmström V; Svenungsson E; Gunnarsson I
    PLoS One; 2016; 11(6):e0158076. PubMed ID: 27336701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiphospholipid antibody profiles in lupus nephritis with glomerular microthrombosis: a prospective study of 124 cases.
    Zheng H; Chen Y; Ao W; Shen Y; Chen XW; Dai M; Wang XD; Yan YC; Yang CD
    Arthritis Res Ther; 2009; 11(3):R93. PubMed ID: 19545416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of antiphospholipid antibodies with clinical activity and renal pathological activity in patients with lupus nephritis.
    Zhang J; Zhang J; Zhou Q; Lu G; You X
    Lupus; 2021 Jun; 30(7):1140-1145. PubMed ID: 33832360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiphospholipid antibodies in patients with lupus nephritis: clinical correlations and associations with long-term outcomes.
    Yap DYH; Thong KM; Yung S; Tang C; Ma BMY; Chan TM
    Lupus; 2019 Oct; 28(12):1460-1467. PubMed ID: 31594451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential for glomerular C4d as an indicator of thrombotic microangiopathy in lupus nephritis.
    Cohen D; Koopmans M; Kremer Hovinga IC; Berger SP; Roos van Groningen M; Steup-Beekman GM; de Heer E; Bruijn JA; Bajema IM
    Arthritis Rheum; 2008 Aug; 58(8):2460-9. PubMed ID: 18668574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiphospholipid antibodies are associated with an increased risk for chronic renal insufficiency in patients with lupus nephritis.
    Moroni G; Ventura D; Riva P; Panzeri P; Quaglini S; Banfi G; Simonini P; Bader R; Meroni PL; Ponticelli C
    Am J Kidney Dis; 2004 Jan; 43(1):28-36. PubMed ID: 14712424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of association between antiphospholipid antibody and WHO classification in lupus nephritis.
    Fofi C; Cuadrado MJ; Godfrey T; Abbs I; Khamashta MA; Hughes GR
    Clin Exp Rheumatol; 2001; 19(1):75-7. PubMed ID: 11247329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta2-glycoprotein I Expression in Lupus Nephritis Patients with Antiphospholipid-associated Nephropathy.
    Gao R; Yu W; Wen Y; Li H
    J Rheumatol; 2016 Nov; 43(11):2026-2032. PubMed ID: 27633824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nephropathy associated with antiphospholipid antibodies in patients with systemic lupus erythematosus.
    Silvariño R; Sant F; Espinosa G; Pons-Estel G; Solé M; Cervera R; Arrizabalaga P
    Lupus; 2011 Jun; 20(7):721-9. PubMed ID: 21486929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-beta-2-glycoprotein I domain 1 identifies antiphospholipid antibodies-related injuries in patients with concomitant lupus nephritis.
    Sciascia S; Radin M; Cecchi I; Fenoglio R; De Marchi A; Besso L; Baldovino S; Rossi D; Miraglia P; Rubini E; Roccatello D
    J Nephrol; 2020 Aug; 33(4):757-762. PubMed ID: 31974856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between antiphospholipid antibodies and all-cause mortality among end-stage renal disease patients with and without SLE: a retrospective cohort study.
    Broder A; Mowrey WB; Kim M; Murakhovskaya I; Billett H; Neugarten J; Costenbader KH; Putterman C
    Rheumatology (Oxford); 2016 May; 55(5):817-25. PubMed ID: 26705328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of antibodies to beta2-glycoprotein 1 from patients with systemic lupus erythematosus.
    Cabral AR; Cabiedes J; Alarcón-Segovia D
    Lupus; 2004; 13(3):182-7. PubMed ID: 15119547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiphospholipid antibodies and renal outcomes in patients with lupus nephritis.
    Tsuruta Y; Uchida K; Itabashi M; Yumura W; Nitta K
    Intern Med; 2009; 48(21):1875-80. PubMed ID: 19881237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Laboratory and morphologic parameters in patients with lupus nephritis].
    Rasković S; Bogić M; Perić-Popadić A; Stefanović L; Arandjelović S; Jovicić Z; Bolpacić J; Tomić-Spirić V
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():38-41. PubMed ID: 12583312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiac abnormalities in patients with systemic lupus erythematosus: the role of antiphospholipid antibodies].
    Monti M; Borgognoni F; Pastacci L; Vincentelli GM
    G Ital Cardiol (Rome); 2016 Dec; 17(12):1001-1007. PubMed ID: 28151504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
    Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE
    Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombotic microangiopathy and poor renal outcome in lupus patients with or without antiphospholipid syndrome.
    Hernandez-Molina G; García-Trejo LP; Uribe N; Cabral AR
    Clin Exp Rheumatol; 2015; 33(4):503-8. PubMed ID: 26203932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.